Navigation Links
Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA Conference
Date:2/20/2008

Evidence Base for MEDIHONEY(TM) Dressings Growing

PRINCETON, N.J., Feb. 20 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that four abstracts detailing the clinical usage of its newly released MEDIHONEY(TM) Wound & Burn Dressings with Active Leptospermum Honey were accepted for presentation at the upcoming annual American Professional Wound Care Association conference, held this year between March 6 - 9 in Forth Worth, Texas. Additionally, the company has announced that the use of MEDIHONEY(TM) Dressings is a topic on the general session agenda for the conference.

About the product's recognition at the upcoming conference, CEO Edward Quilty said, "The fact that so many abstracts were developed and accepted at a national conference after only four months on the market speaks volumes to the effectiveness of the MEDIHONEY(TM) dressings. Based on the response and clinical evidence generated while on the market in Europe over the past two years, we had a good sense of what would happen upon our launch in the US and Canada. It is exciting to see the product meeting our very high expectations, and to know that we are contributing to the well-being of many patients who would otherwise have very few options."

The abstracts include the following:

"Chronic Lower Extremity Ulceration -- Use of a Leptospermum Impregnated Alginate to Accelerate Wound Closure", Dr. Matt Regulski, DPM, Toms River Foot and Ankle Surgical Associates, New Jersey.

"Clinical Application of Absorbent Calcium Alginate Dressing Pads, Containing Manuka (Leptospermum) Honey, in Infected Lower Extremity Venous Ulcers", Dr. Paul Kesselman, DPM, Brooklyn, NY

"Favorable Treatment Outcomes of Chronic Leg Ulcers with the Use of a New Leptospermum Honey Alginate Dressing", Dr. Paul A. Ligouri, MD and Kim L. Peters, RN, CWS, Whittier Rehabilitation Hospital, Haverhill, MA.
'/>"/>

SOURCE Derma Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. 1st EMEA application filed for product using innovative intradermal microinjection system BD Soluvia
2. PriCara(TM) Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches
3. NeoStrata Clinical Findings Reveal Benefits of Combining Glycolic Acid Peels and Targeted Home Care With Microdermabrasion for Optimized Treatment of Photodamaged Skin
4. AGI Dermatics Data Indicates 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1, Increases Collagen and Enhances DNA Repair
5. Leading Cosmetic Dermatologist, Peter G. Ballas II MD, Retains Kay Renz Public Relations to Promote his Practice and New Skincare Line
6. Prominent Cosmetic Dermatologist and Author Joins MySkinCareConnection.com
7. Dr. Neil Sadick Presents on Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
8. LOreal USA Announces Three-Year Support of Womens Dermatologic Society Foundation Community Outreach
9. Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology
10. American Academy of Dermatology Caught in Pay-for-Play Scandal
11. New Technology and Improved Techniques Arm Dermatologists With Tools to Minimize Facial Scars From Skin Cancer Surgery

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...y, study finds, , , MONDAY, Nov. 9 (Hea...ug Plavix (clopidogrel) works about the same in wo...s has found. , "After this study, I can say we ...th this very important drug," said Dr. Jeffrey S. ...ew York University Langone Medical Center in New Y...
(Date:11/9/2009)...ditions are age-related, researchers say , ...urgery doesn,t appear to speed the progression of ...to a new study that challenges the belief that tre..., "Because both conditions are strongly age-rel...," wrote Li Ming Dong, of Stony Brook University S...
(Date:11/9/2009)... sexual function, study says, , , MON...ble to restore sexual function to rabbits with dam...ab and implanting it, a new study reports. , Th...s say the technique could one day be used to treat... able to show the tissue was able to integrate and...
(Date:11/9/2009)...s are often blamed for the increasing rates of chi...wever finds that 80% of people think that parents ... (PRWEB) November 9, 2009 -- If you th...d Australia’s obesity epidemic, think again....rs. A recent survey commissioned for Fitness.com....
(Date:11/9/2009)...ights positive influence of sports participation o... IL (Vocus) November 9, 2009 -- As people age frac...esearch has highlighted the importance of exercise...ues. However, a new study published in the Novembe...inary Approach reveals that there may be signific...
Breaking Medicine News(10 mins):Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids 2Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2
... Gay and lesbian civil partnerships (gay marriage)... benefits. Researchers said that such marriage lea...ariety of ways. // Civil partnerships for gay coup...the Journal of Epidemiology and Community Health s...
... Sudden Infant Death is thought to be spurred by t...ists from Bristol, England, have been able to asce...y of Bristol researchers have found certain sets o...ers.' The research team, led by Professor Julia...
... The state government is facing accusation from th...f health services in the state. // Reports are... a relapse within a month of being discharged from...alls, during the previous year. Apparently the gov...
... A new study published in the March 15, 2006 issue...n Cancer Society, says that the risk of a //new ca...ral breast cancer increases to a fair degree in wo...ith hereditary (non-BRCA) breast cancer greatly in...
... It has been proposed by the Jharkhand government ...mdev to exploit the potential of Ayurveda.// The y...y for manufacture and marketing of Ayurvedic medic... Ramdev next week when he arrives here for a yoga ...
... South East Asia has been long considered a wonder...bars, hotel lobbies or restaurants without any inh... the government is seriously thinking about imposi...nt offices, airports and other public venues like ...
Other Medicine News:Health News:Smoking Ban To Be Soon Implemented In South East Asian Bars 2
(Date:11/9/2009)..., VIRGINIA BEACH, Va., Nov. 9 Lif...ny, announces the launch of Vertigraft Cervical Bi..., Preservon® is a new, proprietary glycero...t bio-implants to be stored in a fully hydrated st...ed to freeze or freeze-dry bio-implants, doing awa...
(Date:11/9/2009)..., MIAMI, Nov. 9 ISTA Ph...ced additional results from the Company,s Bepreve(...% Phase 3 clinical studies. These results were pr...ing of the American College of Allergy, Asthma &am...n a poster presentation titled, "Treatment of Ocul...
(Date:11/9/2009)..., WALTHAM, Mass., Nov. 9 Decision...d advisory firms for pharmaceutical and healthcare...th factor receptor 2 (HER2) targeting therapies --...mithKline/Nippon Kayaku,s Tykerb/Tyverb -- were th...tment. Continued uptake of Herceptin and Tykerb/Ty...
Breaking Medicine Technology:LifeNet Health Announces First Bio-Implant with New Preservation Technology 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2Cyberonics Reports Strong Fiscal 2010 First Quarter Results 54925 1Cyberonics Reports Strong Fiscal 2010 First Quarter Results 54925 2Cyberonics Reports Strong Fiscal 2010 First Quarter Results 54925 3Cyberonics Reports Strong Fiscal 2010 First Quarter Results 54925 4Cyberonics Reports Strong Fiscal 2010 First Quarter Results 54925 5Cyberonics Reports Strong Fiscal 2010 First Quarter Results 54925 6Cyberonics Reports Strong Fiscal 2010 First Quarter Results 54925 7Cyberonics Reports Strong Fiscal 2010 First Quarter Results 54925 8Cyberonics Reports Strong Fiscal 2010 First Quarter Results 54925 9Cyberonics Reports Strong Fiscal 2010 First Quarter Results 54925 10Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 1Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 2Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 3Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 4Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 5Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 6Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 7Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 8Results In The New England Journal Of Medicine Confirm Novartis Drug Femara 28R 29 Is Superior To Tamoxifen After Breast Cancer Surgery 4872 9Medical Heroin Helps Treatment Resistant Addicts 54920 1Medical Heroin Helps Treatment Resistant Addicts 54920 2Medical Heroin Helps Treatment Resistant Addicts 54920 3
...or Medical Use Approval and Insurance Coverage Var...OCHESTER, N.Y. - April 30, 2007-- Most U.S. adults...nd procedures that can,impact people,s quality of ... fertilization, drugs to treat erectile,dysfunctio... Large,majorities also believe these types of trea...
... N.Y.--(BUSINESS WIRE)--May 1, 2007 - Progenics,Ph... positive,results from the first clinical trial of... infected with the human immunodeficiency,virus (H...ng a,single 5.0 mg/kg dose of PRO 140 achieved an ...n the blood of 98.5% (1.83,log10), with individual...
Other Medicine Technology:Eighty-one Percent of U.S. Adults say that Birth Control Pills and,Procedures Should Be Covered by Health Insurance 2Eighty-one Percent of U.S. Adults say that Birth Control Pills and,Procedures Should Be Covered by Health Insurance 3Eighty-one Percent of U.S. Adults say that Birth Control Pills and,Procedures Should Be Covered by Health Insurance 4Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 2Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 3Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 4Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 5Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 6Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 7
Onyx® II 9550
FetalSAT™
8600FO MRI
2100 Pulse Oximeter
Medicine Products: